4.59 USD
▼-0.23-4.77%
盘后 5.02 0.00%
2026-09-16
市值
$3.86M
市盈率
—
EPS
-99.79
股息率
—
52 周区间
4.40 – 2,671.20
成交量
16.31K
Beta
-0.30
目标价
—
52W 低 4.4052W 高 2,671.20
价格走势
公司简介
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company’s lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research a...